期刊
TRENDS IN CANCER
卷 4, 期 11, 页码 769-783出版社
CELL PRESS
DOI: 10.1016/j.trecan.2018.09.003
关键词
-
类别
资金
- US National Institutes of Health (NIH) [R01-CA155693]
- Department of Defense [W81XWH-14-1-0575, W81XWH-16-1-0575]
- Chinese Ministry of Science and Technology (MOST) [2016YFA0101203]
- NIH [R21CA218635]
- Roswell Park Comprehensive Cancer Center
- National Cancer Institute (NCI) [P30CA016056]
Prostate cancer (PCa) has a predominantly luminal phenotype. Basal cells were previously identified as a cell of origin for PCa, but increasing evidence implicates luminal cells as a preferred cell of origin for PCa, as well as key drivers of tumor development and progression. Prostate luminal cells are understudied compared with basal cells. In this review, we describe the contribution of prostate luminal progenitor (LP) cells to luminal cell development and their role in prostate development, androgen-mediated regeneration of castrated prostate, and tumorigenesis. We also discuss the potential value of LP transcriptomics to identify new targets and therapies to treat aggressive PCa. Finally, we propose future research directions focusing on molecular mechanisms underlying LP cell biology and heterogeneity in normal and diseased prostate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据